Recent Investment Analysts’ Ratings Changes for Extendicare (EXE)

A number of research firms have changed their ratings and price targets for Extendicare (TSE: EXE):

• 5/13/2026 – Extendicare had its price target raised by BMO Capital Markets from C$30.00 to C$38.00.
• 5/12/2026 – Extendicare had its price target raised by National Bank Financial from C$32.00 to C$34.00. They now have an “outperform” rating on the stock.
• 5/11/2026 – Extendicare was upgraded by Canaccord Genuity Group Inc. to “strong-buy”.
• 5/11/2026 – Extendicare had its price target raised by TD from C$32.00 to C$39.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Extendicare was given a new C$34.50 price target by Desjardins. They now have a “buy” rating on the stock.
• 4/6/2026 – Extendicare was upgraded by TD Securities from “hold” to “buy”. They now have a C$32.00 price target on the stock, up from C$19.00.
• 4/2/2026 – Extendicare had its price target raised by Canadian Imperial Bank of Commerce from C$22.00 to C$32.00.

Extendicare Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 15th will be paid a dividend of $0.0441 per share. The ex-dividend date is Friday, May 29th. This represents a c) annualized dividend and a yield of 1.6%. Extendicare’s payout ratio is presently 37.24%.

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.